Tag: oral immunotherapy (OIT)

Palforzia Capsules with Logo

Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...

Peanut-allergic patients treated with Palforzia showed desensitization to peanut protein with a predictable safety profile at nine months
Wheat

Wheat OIT Shows Potential for Children in Small Study

Study provides insight into the effectiveness of oral immunotherapy for wheat allergy.
Eggs

Egg Oral Immunotherapy Could be Better Option than Baked Egg Therapy...

5 year multi-site study shows egg OIT was significantly more likely to achieve sustained unresponsiveness compared to children opting for baked egg therapy.
Palforzia

New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued...

After 2 Years of Daily Treatment, More Than 80% of Patients Were Successfully Desensitized to 2000 mg Peanut Protein or Equivalent of About 14 Peanut Kernels.
Pill

New Pill Could Prevent Anaphylaxis in People with Food, Drug Allergies

Drug would be the first known treatment to prevent anaphylaxis.
FARE OIT Webinar

Oral Immunotherapy: What You Should Know, and What’s New (Webinar)

In FARE's webinar you’ll hear the latest on cutting-edge studies on new food allergy treatments.
Palforzia Capsules with Logo

Aimmune Provides FDA Mandated Program for Patients Considering Treatment of Peanut...

The FDA seeks to mitigate risks associated with treatment by mandating a program that must be followed by patients, prescribers, pharmacies, and healthcare settings.
Tablets

Study: Co-Treatments Like Antihistamines and Probiotics Make Peanut OIT Success in...

“These findings suggest that slight modifications to treatment protocols could play a key role in substantially improving treatment safety.”
AAAAI Palforzia Release

What You Need to Know About the First Peanut Allergy Treatment...

Information for patients and their families about this new treatment option, what it means, and why it won’t be right for everyone.